Metsurge GP 1 mg/500 mg Tablet
Manufacturer
Obsurge Biotech Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Key Information
Short Description
Metsurge GP 1 mg/500 mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels.
Dosage Form
Tablet
Introduction
Metsurge GP 1 mg/500 mg Tablet is a combination of two medicines, Glimepiride and Metformin, used to treat type 2 diabetes mellitus in adults. Glimepiride increases insulin release from the pancreas, while Metformin lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin. This combination helps control blood sugar levels effectively. However, it may cause side effects such as hypoglycemia, lactic acidosis, and liver function abnormalities. It is important to monitor blood sugar levels regularly and consult a doctor for any unusual symptoms.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Metsurge GP 1 mg/500 mg Tablet is to be taken with food.
How it works
Metsurge GP 1 mg/500 mg Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines, and increasing the body's sensitivity to insulin.
Quick Tips
You have been prescribed this combination medicine as it can control blood sugar better than metformin alone. You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Metsurge GP 1 mg/500 mg Tablet. Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting, and stomach pain as Metsurge GP 1 mg/500 mg Tablet may cause a rare but serious condition called lactic acidosis. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Metffil G1 Tablet
Glimfirst M1 Tablet
Insurol 1mg/500mg Tablet
Glimihex M 1mg/500mg Tablet
Gpglim M 1mg/500mg Tablet
Glycon G 1mg/500mg Tablet
Glimbeta M 1mg/500mg Tablet
Phnride M 1mg/500mg Tablet
Defmet G 1mg/500mg Tablet
Glimcloud-M 1 Tablet
Frequently asked questions
What are the recommended storage conditions for Metsurge GP 1 mg/500 mg Tablet?
Store Metsurge GP 1 mg/500 mg Tablet in its original container, tightly closed, according to the instructions provided on the packaging or label. Dispose of any unused medication and ensure it is not accessible to pets, children, or other individuals.
Can the use of Metsurge GP 1 mg/500 mg Tablet lead to lactic acidosis?
Yes, the use of Metsurge GP 1 mg/500 mg Tablet can lead to lactic acidosis, a rare but serious medical emergency characterized by elevated blood lactate levels. This condition is more likely to occur in patients with underlying kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, feeling cold in the arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or slow heart rate. If you experience these symptoms, discontinue use and consult your doctor immediately.
What is Metsurge GP 1 mg/500 mg Tablet?
Metsurge GP 1 mg/500 mg Tablet is a combination medication containing Glimepiride and Metformin. It is used to treat type 2 diabetes mellitus (DM) in adults, improving blood glucose levels when taken with a proper diet and regular exercise. Glimepiride increases insulin release from the pancreas, while Metformin reduces glucose production in the liver and improves insulin sensitivity. This combination is not indicated for the treatment of type 1 DM.
What are the possible side effects of Metsurge GP 1 mg/500 mg Tablet?
Common side effects associated with Metsurge GP 1 mg/500 mg Tablet include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects may include lactic acidosis. Long-term use can also lead to Vitamin B12 deficiency, which may cause anemia, nerve problems, and symptoms such as tingling sensations, numbness, weakness, urinary issues, changes in mental status, and difficulty maintaining balance.
Can the use of Metsurge GP 1 mg/500 mg Tablet lead to Vitamin B12 deficiency?
Yes, the use of Metsurge GP 1 mg/500 mg Tablet can cause Vitamin B12 deficiency on long-term use, as it interferes with stomach absorption. Untreated deficiency may lead to anemia, nerve problems, and symptoms such as tingling sensations, numbness, weakness, urinary issues, changes in mental status, and difficulty maintaining balance. To avoid these issues, consider taking Vitamin B12 supplements at least once a year.
Can the use of Metsurge GP 1 mg/500 mg Tablet cause hypoglycemia?
Yes, Metsurge GP 1 mg/500 mg Tablet can cause hypoglycemia (low blood sugar). Symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, consume alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and keep a quick source of sugar, such as glucose tablets, honey, or fruit juice, readily available.
Is it safe to take alcohol while I am also taking Metsurge GP 1 mg/500 mg Tablet?
No, it is not recommended to consume alcohol while taking Metsurge GP 1 mg/500 mg Tablet, as it may lower blood sugar levels and increase the risk of hypoglycemia and lactic acidosis.
